Major survey launched to map haemophilia across Asia-Pacific

NCT ID NCT07163260

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

Summary

This study aims to better understand how haemophilia affects people and how it is managed in Asia-Pacific countries. It is a survey-based study, so no medications or treatments are provided to participants. Researchers will collect information from patients, caregivers, doctors, and patient organizations to learn about the disease's prevalence and the current care landscape.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novo Nordisk Investigational Site

    Bangalore, Karnataka, 560 066, India

  • Novo Nordisk Investigational Site

    Kuala Lumpur, 50470, Malaysia

  • Novo Nordisk Investigational Site

    Seoul, South Korea

  • Novo Nordisk Investigational Site

    Bangkok, 10500, Thailand

Conditions

Explore the condition pages connected to this study.